Characteristics of state prescription drug monitoring programs: a state‐by‐state survey

Abstract

Characteristics of PDMPs are heterogeneous throughout the country. Standardizing data capture, availability, and reporting would improve their usefulness for providers. Copyright © 2016 John Wiley & Sons, Ltd.

Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing

“…Prescription Drug Monitoring Programs (PDMPs) are state-level electronic registries of prescription drugs dispensed, with the majority of the data being reported by community-based pharmacies for scheduled medications (Bao et al, 2016). Forty-nine states have implemented PDMPs (Manasco et al, 2016; Finley et al, 2017). Early PDMPs (the 1990s) were used to monitor and detect illicit distribution of schedule II medications, and while there is some variation across states regarding the purpose of the PDMP (Katz et al, 2008); many today are being used as a tool to monitor over-prescribing at the provider level and doctor-shopping (obtaining a similar prescription from multiple prescribers) at the patient level (Clark et al, 2012).…”

“…Given the significant between-state variations in PDMPs (Manasco et al, 2016), there is an increasing amount of research investigating whether specific PDMP characteristics are associated with positive outcomes. Seventeen states mandate PDMP enrollment and only eight states require prescribers to review a patient’s PDMP report before prescribing controlled substances (Manasco et al, 2016).…”

“…Seventeen states mandate PDMP enrollment and only eight states require prescribers to review a patient’s PDMP report before prescribing controlled substances (Manasco et al, 2016). Mandatory use of the PDMP is associated with decreases in the quantity of opioids dispensed, the number of opioids prescriptions and multiple provider episodes (MPEs) (Rasubala et al, 2015; Freeman et al, 2015; PDMP Center of Excellence, 2014).…”

Influence of Medical Insurance Under the Affordable Care Act on Access to Pain Management of the Trauma Patient

“…15 Those individuals of the trauma patient population are increasingly being confronted with a medical landscape that is ill prepared to manage all aspects associated with postoperative surgical pain. This becomes even more challenging as PCPs, orthopedic surgeons and pain management specialists will change how opioid prescription behavior can vary in response to individual state prescription monitoring services 16 , ever-present concerns of legal ramifications associated with prescribing opioid analgesics, inappropriate management of chronic opioid dependent patients, and an increasing awareness of the many negative consequences associated with opioid analgesic medications.…”

Diversion Alert: 1-Year Evaluation Across Northern New England, 2013–2014

“…For example, naloxone availability and treatment programs have multiplied (7), changes have occurred in clinical guidelines and in the development of abuse resistant opioids (8), and adoption of prescription drug monitoring programs (PDMPs) has been almost universal (in 49 of 50 states), although characteristics of these programs vary by state (9). Although federal efforts, including grant funding, are substantial and span several federal agencies (eg, Substance Abuse and Mental Health Services Administration, Health Resources and Services Administration, Drug Enforcement Agency), there has not yet been a systematic approach to linking health system and law enforcement efforts as a means to more effectively address prescription drug abuse and diversion.…”